Bill
HB 5475
HB 5475 targets fertility fraud by physicians, defines deceptive acts, and enables penalties and investigations to protect patients and hold clinics/doctors accountable.
HB 5475 – AN ACT CONCERNING FERTILITY FRAUD BY PHYSICIANS
Overview
- Purpose: To address and deter fertility-related fraud by physicians. The bill appears aimed at protecting patients undergoing fertility treatments and ensuring accountability for physicians suspected of fraudulent or deceptive conduct in fertility practices.
What the bill covers (based on the title and subject)
- The bill’s focus is fertility fraud by physicians, which typically would involve deceptive or dishonest practices in fertility treatment contexts. While the full text is not provided here, such legislation commonly seeks to:
- Define what constitutes fertility fraud (e.g., misrepresentation, tampering with donor gametes, mislabeling or switching embryos, unauthorized use of patient materials).
- Establish penalties or sanctions for physicians who engage in fraud.
- Create enforcement mechanisms, such as reporting requirements to medical boards or licensing authorities.
- Provide civil remedies or damages to affected patients.
- Set procedural requirements for investigations and possible disciplinary actions.
Potential provisions you might expect (inferred from the bill’s purpose)
- Definitions: Clear terms for “fertility fraud,” “physician,” “donor gametes,” “embryos,” and related concepts.
- Prohibited conduct: Specific acts deemed fraudulent or deceptive in fertility treatment.
- Sanctions and enforcement: Possible disciplinary actions by medical boards, licensing penalties, or criminal penalties.
- Reporting and investigations: Obligations to report suspected fraud and timelines for investigations.
- Patient remedies: Civil liability, compensatory damages, and any available equitable relief.
- Confidentiality and privacy: Protections for patient information and confidentiality requirements for clinics.
- Oversight and accountability: Requirements for clinics or practitioners to maintain records and comply with standards.
Who would be affected
- Patients: Individuals undergoing fertility treatments who may be at risk of fraud or deception.
- Physicians and fertility clinics: Practitioners and facilities providing fertility services, who could face investigations, sanctions, or civil liability.
- Medical licensing and disciplinary bodies: Agencies responsible for oversight of physician conduct.
- Insurers and payers: Entities that may be involved in covering fertility procedures and potential fraud-related claims.
Procedural and timeline notes
- Introduced: March 14, 2025.
- Initial referral: January 17, 2025, to the Joint Committee on Judiciary.
- Filed: March 14, 2025.
- Legislative actions: Read in (April 7, 2025); listed as referred to Energy Resources on April 7, 2025.
- Current status: The bill has been tied to committee referrals; there is a noted discrepancy between the stated status (Judiciary) and the latest committee action (Energy Resources). This indicates the bill is in the committee process and has not yet advanced to final passage as of the latest actions.
Notes and next steps
- Text unavailable: The precise provisions, definitions, penalties, and procedures are not provided here. For a complete and precise understanding, consult the official bill text and the bill’s fiscal notes.
- If advancing, watch for: Amendments during committee consideration, shifts in committee assignment, and potential floor votes. Timelines depend on the legislative calendar and committee action.
This summary highlights the bill’s intended focus on preventing and penalizing fertility fraud by physicians, the likely areas it would address, and the current committee-processing status based on available action notes.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
